Moreover, we showed that the high expression of RPS7 and low-expression of HIF-1α were significantly associated with good progression-free and/or overall survivals in stage IV CRC patients, which may be used as potential markers for diagnosis and clinical treatment of advanced colorectal cancer. The gene discussed is RPS7; the disease is colorectal carcinoma.